We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Nymox Pharmaceutical Corp is a biopharmaceutical company focused on developing its drug candidate, NX-1207, for the treatment of BPH and the treatment of low-grade localized prostate cancer. Nymox Pharmaceutical Corp is a biopharmaceutical company focused on developing its drug candidate, NX-1207, for the treatment of BPH and the treatment of low-grade localized prostate cancer.
nullnullnullnullnullnull
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | -0.1766 | -46.8932554434 | 0.3766 | 0.495 | 0.1688 | 128261 | 0.29703093 | CS |
156 | -2.23 | -91.7695473251 | 2.43 | 2.87 | 0.1688 | 229101 | 1.09594981 | CS |
260 | -1.83 | -90.1477832512 | 2.03 | 4.9 | 0.1688 | 191599 | 1.69171212 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions